ADACT announce over 1,000 PMTA submissions

16 September 2020

We are proud to announce the successful submission of over 1,000 applications on behalf of 20 major electronic cigarette and vaping brands.

Following the FDA’s decision to push back the introduction of the Premarket Tobacco Product Application (PMTA) from 12 May to 9 September, the ADACT team have worked tirelessly to deliver the documentation required for companies continued sales in the United States of America.

ADACT’s Chief Regulatory Officer, Damien Bové, said “PMTA has been an incredible challenge for the industry in terms of both understanding the initial requirements and filing the subsequent applications.

“Even though we were able to use our experience with Tobacco Products Directive (TPD) to streamline our working processes for PMTA, these initial applications represent thousands of hours work and are a major achievement for our incredible team.”

The world class regulatory compliance knowledge held by the ADACT team attracted many new electronic cigarette and vaping brands to work with us for the first time on their PMTA submissions. To these and our many existing clients, we can only say we are proud to have been entrusted with this huge responsibility and look forward to working with you on future regulatory compliance challenges.

Read more about ADACT’s PMTA programme here…

To book a face to face or virtual meeting about PMTA, please call ADACT on +44(0)1302 986 088 or email sales@adactmedical.com. The ADACT team are working from our Doncaster centre as normal with extra safety precautions in place and look forward to hearing from you soon.

 

Get in touch with ADACT

Lorem ipsum dolor sit amet, consectetur adipiscing elit